| scholarly article | Q13442814 |
| P50 | author | Timothy F. Cloughesy | Q47159504 |
| Phioanh Nghiemphu | Q59440413 | ||
| Linda Liau | Q59749173 | ||
| Paul Mischel | Q61594836 | ||
| Albert Lai | Q89181819 | ||
| Reema Mody | Q114422971 | ||
| Reshmi Chowdhury | Q114444386 | ||
| Jean K. Reiss | Q114444390 | ||
| Robert M. Prins | Q41926442 | ||
| P2093 | author name string | Fei Liu | |
| Weidong Chen | |||
| Tie Li | |||
| Arthur P Chou | |||
| Horacio Soto | |||
| William H Yong | |||
| Jerry J Lou | |||
| Sichen Li | |||
| P2860 | cites work | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells | Q21245271 |
| MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators | Q24336898 | ||
| MicroRNA targeting specificity in mammals: determinants beyond seed pairing | Q24607724 | ||
| Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma | Q24612429 | ||
| miRBase: integrating microRNA annotation and deep-sequencing data | Q24615914 | ||
| Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases | Q24632807 | ||
| A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion | Q24633772 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Releasing the block: setting differentiation free with mutant IDH inhibitors. | Q42498717 | ||
| Epigenetic inactivation of the MIR34B/C in multiple myeloma. | Q43422429 | ||
| Promoter2.0: for the recognition of PolII promoter sequences. | Q52212327 | ||
| Methylation of the TWIST1 promoter, TWIST1 mRNA levels, and immunohistochemical expression of TWIST1 in breast cancer. | Q54504122 | ||
| Calcium metabolism, serum thyroid-stimulating hormone, prolactin, and growth hormone in spontaneously hypercholesterolemic rats | Q69957879 | ||
| An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells. | Q27852141 | ||
| Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
| MicroRNA signatures in human cancers | Q27860962 | ||
| CpG islands in vertebrate genomes | Q27861045 | ||
| Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs | Q27861053 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation | Q29615366 | ||
| IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype | Q29617457 | ||
| Primary brain tumours in adults. | Q30765293 | ||
| CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer | Q33235269 | ||
| Preparation of reduced representation bisulfite sequencing libraries for genome-scale DNA methylation profiling | Q33848902 | ||
| Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer. | Q34049709 | ||
| Molecular and Enzymatic Profiles of Mammalian DNA Methyltransferases: Structures and Targets for Drugs | Q34143019 | ||
| DNA methylation silences miR-132 in prostate cancer. | Q34252550 | ||
| 5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft. | Q34374136 | ||
| Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. | Q34384312 | ||
| The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer | Q34441849 | ||
| Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. | Q35609699 | ||
| The microcosmos of cancer | Q36432986 | ||
| A heterozygous IDH1R132H/WT mutation induces genome-wide alterations in DNA methylation. | Q36446183 | ||
| Identification of retinol binding protein 1 promoter hypermethylation in isocitrate dehydrogenase 1 and 2 mutant gliomas. | Q36486875 | ||
| Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation. | Q36500377 | ||
| A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. | Q36603339 | ||
| Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome | Q36627170 | ||
| A microRNA DNA methylation signature for human cancer metastasis | Q36861111 | ||
| Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine. | Q37381606 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| Structure and function of mammalian DNA methyltransferases. | Q37829700 | ||
| The definition of primary and secondary glioblastoma | Q38064831 | ||
| MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer | Q39428859 | ||
| MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer | Q39458980 | ||
| Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. | Q39514244 | ||
| The silencing of microRNA 148a production by DNA hypermethylation is an early event in pancreatic carcinogenesis. | Q39709103 | ||
| Genome-wide analysis in a murine Dnmt1 knockdown model identifies epigenetically silenced genes in primary human pituitary tumors. | Q39928909 | ||
| MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. | Q41412954 | ||
| P433 | issue | 22 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | CpG island | Q1138360 |
| hypermethylation | Q106875739 | ||
| P304 | page(s) | 5808-5822 | |
| P577 | publication date | 2014-09-15 | |
| P1433 | published in | Clinical Cancer Research | Q332253 |
| P1476 | title | Tumor-suppressive miR148a is silenced by CpG island hypermethylation in IDH1-mutant gliomas | |
| P478 | volume | 20 |
| Q40163473 | Commercial rodent diets differentially regulate autoimmune glomerulonephritis, epigenetics, and microbiota in MRL/lpr mice |
| Q53433176 | D-2-Hydroxyglutarate Is Necessary and Sufficient for Isocitrate Dehydrogenase 1 Mutant-Induced MIR148A Promoter Methylation. |
| Q38861997 | DNA methylation in adult diffuse gliomas |
| Q33623176 | Downregulation of miR-301a-3p sensitizes pancreatic cancer cells to gemcitabine treatment via PTEN |
| Q47260412 | EZH2-, CHD4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients |
| Q28087759 | Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer |
| Q90025515 | Friend or foe-IDH1 mutations in glioma 10 years on |
| Q38664137 | Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases |
| Q37702193 | IGFBP2 expression predicts IDH-mutant glioma patient survival |
| Q38526029 | Impending Impact of Molecular Pathology on Classifying Adult Diffuse Gliomas. |
| Q33648875 | MiR-148a increases glioma cell migration and invasion by downregulating GADD45A in human gliomas with IDH1 R132H mutations |
| Q35744993 | MiR-148a, a microRNA upregulated in the WNT subgroup tumors, inhibits invasion and tumorigenic potential of medulloblastoma cells by targeting Neuropilin 1. |
| Q36771820 | MicroRNA-708-5p acts as a therapeutic agent against metastatic lung cancer. |
| Q26863394 | New developments in the pathogenesis and therapeutic targeting of the IDH1 mutation in glioma |
| Q50105894 | Preeclampsia is associated with hypermethylation of IGF-1 promoter mediated by DNMT1. |
| Q38885469 | Relationship Between Noncoding RNA Dysregulation and Epigenetic Mechanisms in Cancer |
| Q36756817 | The Cancer Genome Atlas Analysis Predicts MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma. |
| Q26743549 | The Role of Mir-148a in Cancer |
| Q61799101 | miR-148a regulates expression of the transferrin receptor 1 in hepatocellular carcinoma |
| Q93173352 | miR‑296‑3p promotes the proliferation of glioblastoma cells by targeting ICAT |
Search more.